LRP1 and Alzheimer disease: Studies have shown that downregulation of LRP1 leads to net accumulation of Aβ in the brain, which exacerbates neurodegeneration and creates a positive feedback loop in AD pathology by activating the pro-inflammatory phenotype of microglia (Jaeger et al., 2009).